Amazon to Remove Seven Eyedrop Products Following FDA Warning

The move comes amid a series of recalls and warnings about over-the-counter eyedrop products, some of which have been linked to serious health risks including infections and vision loss.

Amazon is removing seven eyedrop products from its platform following a warning from the FDA, which stated that the products are not FDA-approved and pose a significant public health risk.
The products, which include Similasan Pink Eye Relief, The Goodbye Company Pink Eye, Can-C Eye Drops, Optique 1 Eye Drops, OcluMed Eye Drops, TRP Natural Eye Floaters Relief, and Manzanilla Sophia Chamomile Herbal Eye Drops, are being removed due to their potential to bypass the body's natural defenses.
This action follows a series of recalls and warnings about over-the-counter eyedrop products, including a warning last month from the FDA urging customers to stop using 26 products due to the risk of eye infections that could lead to vision loss or blindness.
The FDA has given Amazon 15 days to notify the agency of the steps they are taking to correct any violations.
Earlier this year, several eyedrop products were linked to infections, vision loss, and at least one death.